Shares of Rubrik, Inc. RBRK rose sharply in today's pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance above estimates.
Rubrik reported quarterly losses of 61 cents per share, which beat the analyst consensus estimate for losses of 80 cents. Quarterly revenue clocked in at $258.1 million, which beat the analyst consensus estimate of $233.1 million.
Rubrik shares climbed 20.8% to $66.84 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Radius Recycling, Inc. RDUS rose 108.7% to $28.51 in pre-market trading after the company agreed to be acquired by US subsidiary of Toyota Tsusho for $30.00 per share in cash.
- Applied Optoelectronics, Inc. AAOI gained 56.5% to $24.83 in pre-market trading after the company announced a warrant issuance agreement transaction with Amazon for 7,945,399 shares.
- MEDIROM Healthcare Technologies Inc. MRM gained 48.6% to $0.91 in pre-market trading. MEDIROM Mother Labs executive made an additional investment in Mother Labs’ Series A financing at a pre-money valuation of JPY9 billion.
- Cellectis S.A. CLLS gained 40.3% to $1.81 in pre-market trading after the company announced upbeat financial results for the fourth quarter.
- Bit Origin Ltd BTOG gained 37.2% to $0.3743 in pre-market trading after declining 26% on Thursday.
- Digital Ally, Inc. DGLY gained 23.2% to $0.0978 in pre-market trading. Digital Ally has been granted six new patents covering diverse sectors.
- TransCode Therapeutics, Inc. RNAZ rose 19% to 0.8827. TransCode Therapeutics, on Thursday, announced Safety Review Committee approval to open a fourth cohort of its Phase I/II Clinical trial of TTX-MC138.
- DocuSign, Inc. DOCU gained 12.2% to $83.75 in pre-market following better-than-expected fourth-quarter financial results.
- Ulta Beauty, Inc. ULTA rose 7% to $336.26 in pre-market trading as the company reported stronger-than-expected fourth-quarter financial results. Ulta Beauty expects fiscal year 2025 revenue of $11.5 billion to $11.6 billion versus estimates of $11.67 billion, according to Benzinga Pro. The company anticipates full-year earnings of $22.50 to $22.90 per share versus estimates of $23.50 per share.
Losers
- Xponential Fitness, Inc. XPOF shares fell 30.8% to $8.39 in pre-market trading after the company announced fourth-quarter results.
- Linkage Global Inc LGCB declined 21.8% to $0.1797 in pre-market trading.
- Septerna, Inc. SEPN dipped 21.4% to $5.02 in pre-market trading after falling 5% on Thursday.
- Olema Pharmaceuticals, Inc. OLMA fell 15.1% to $3.71 in pre-market trading.
- Icon Energy Corp. ICON shares fell 14.7% to $0.1160 in pre-market trading. ICON Energy received non-compliance letter from the Nasdaq.
- Regencell Bioscience Holdings Limited RGC fell 13.4% to $12.20 in pre-market trading. Relevant Gold closed second tranche of upsized $8.5 million non-brokered private placement led by strategic investors Kinross and Bollinger.
- ImmunoPrecise Antibodies Ltd. IPA fell 11.8% to $0.3572 in today's pre-market trading. ImmunoPrecise Antibodies shares gained over 11% on Thursday after the company announced a strategic partnership to advance antibody-drug conjugates and bispecific antibodies for cancer.
- SenesTech, Inc SNES shares tumbled 10% to $2.16 in pre-market trading after gaining 5% on Thursday. SenesTech recently reported better-than-expected quarterly EPS results.
- SI-BONE, Inc. SIBN fell 8.2% to $13.51 in pre-market trading. SI-BONE recently reported better-than-expected fourth-quarter EPS results and issued FY25 sales guidance above estimates.
- XPeng Inc. XPEV shares dipped 5.4% to $23.99 in pre-market trading. XPeng recenty announced to spend up to $13.8 billion on humanoid robots.
Now Read This:
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.